☆ 3.8 Article

Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income Country

VALUE IN HEALTH REGIONAL ISSUES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Allergy

Cost-utility of use of sputum eosinophil counts to guide management in children with asthma

Jefferson Antonio Buendia et al.

Summary: This study evaluated the cost-utility of sputum eosinophil counts in guiding asthma management in children and found that it was cost-effective, reducing costs and improving quality of life. Decision-makers should use this evidence to enhance clinical practice guidelines.

JOURNAL OF ASTHMA (2022)

添加到收藏夹

Article Allergy

SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis

Jefferson Antonio Buendia et al.

Summary: This study assessed the health and economic consequences of SMART, fixed combination, and fixed-dose inhaled corticosteroids in patients with moderate-severe persistent asthma. The results suggest that SMART therapy was found to be cost-effective regarding fixed combination and fixed-dose inhaled corticosteroids, supporting its use in Colombia and potentially in other middle-income countries.

JOURNAL OF ASTHMA (2022)

添加到收藏夹

Article Health Care Sciences & Services

Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia

Jefferson Antonio Buendia et al.

Summary: The study found that dupilumab is not cost-effective at a willingness-to-pay threshold of $19,000 per QALY in Colombia. Decision-makers should consider the evidence presented in this study to improve clinical practice guidelines and further validate these results in other middle-income countries.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2022)

添加到收藏夹

Article Allergy

Cost-utility of azithromycin in patients with severe asthma

Jefferson Antonio Buendia et al.

Summary: The study found that add-on therapy with azithromycin is cost-effective for asthma patients who remain uncontrolled despite treatment with medium or high-dose ICS/LABA.

JOURNAL OF ASTHMA (2022)

添加到收藏夹

Article Allergy

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma

Jefferson Antonio Buendia et al.

Summary: The study found that tiotropium is a cost-effective alternative to omalizumab and standard therapy for uncontrolled allergic asthma, with lower cost and higher quality-adjusted life years. Decision-makers should consider these results to improve clinical practice guidelines and further research in other middle-income countries.

JOURNAL OF ASTHMA (2022)

添加到收藏夹

Article Health Care Sciences & Services

Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia

Buendia Jefferson Antonio et al.

Summary: The study analyzed the cost-utility of benralizumab treatment in adults with severe uncontrolled asthma in Colombia. The results showed that benralizumab would be cost-effective if its cost is reduced by 41% at an incremental cost-effectiveness ratio of $42,746 per QALY gained.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2022)

添加到收藏夹

Article Health Care Sciences & Services

Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia

Oscar Espinosa et al.

Summary: This study examined the healthcare system of the middle-income country Colombia, estimating the cost-effectiveness threshold and exploring the variation of health expenditures and outcomes. The threshold was found to be around one times the GDP per capita, providing valuable insights for decision-making in a managed healthcare system.

HEALTH POLICY AND PLANNING (2022)

添加到收藏夹

Article Health Policy & Services

Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma

Jefferson Antonio Buendia et al.

Summary: This study evaluated the cost-effectiveness of asthma management using fractional exhaled nitric oxide monitoring in patients between 4 and 18 years of age. The results showed that fractional exhaled nitric oxide monitoring was associated with lower total cost and higher QALYs compared to standard therapy, making it a cost-effective option for treating mild to moderate allergic asthma in this age group.

COST EFFECTIVENESS AND RESOURCE ALLOCATION (2021)

添加到收藏夹

Article Respiratory System

Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma

Jefferson Antonio Buendia et al.

Summary: The study found that triple therapy is cost-effective compared to dual therapy for patients with severe asthma, with a potential gain of 1.55 QALYs per patient per year. Sensitivity analysis showed that the base-case results were robust to variations in assumptions and parameters.

BMC PULMONARY MEDICINE (2021)

添加到收藏夹

Article Health Care Sciences & Services

Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective

Jefferson Antonio Buendia et al.

Summary: The study evaluated the budget impact of surfactant therapy for bronchiolitis in critically ill infants in Colombia, showing that using surfactant therapy for infants with severe bronchiolitis requiring mechanical ventilation is cost-saving.

BMC HEALTH SERVICES RESEARCH (2021)

添加到收藏夹

Article Economics

The cost-utility of early use of high-flow nasal cannula in bronchiolitis

Jefferson Antonio Buendia et al.

Summary: This study evaluated the cost-effectiveness of early use of HFNC compared to oxygen by nasal cannula in an infant with bronchiolitis in the emergency setting. The results showed that HFNC was more cost-effective, allowing for a more efficient use of resources in emergency settings, especially in low-resource countries with high prevalence of bronchiolitis.

HEALTH ECONOMICS REVIEW (2021)

添加到收藏夹

Article Medicine, General & Internal

Budget impact analysis of high-flow nasal cannula for infant bronchiolitis: the Colombian National Health System perspective

Jefferson Antonio Buendia et al.

Summary: High-flow nasal cannula was found to be cost-saving in managing infants with acute bronchiolitis in emergency settings in Colombia, with potential savings exceeding $13 million USD over 5 years. The results were robust in univariate sensitivity analysis.

CURRENT MEDICAL RESEARCH AND OPINION (2021)

添加到收藏夹

Letter Allergy

Cost-utility of tiotropium for children with severe asthma in patients aged 1-5 years

Jefferson Antonio Buendia et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2021)

添加到收藏夹

Article Pediatrics

Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma

Jefferson Antonio Buendia et al.

Summary: The study found that adding low-dose budesonide-formoterol as a reliever to usual care for adolescents with mild asthma is cost-effective. This conclusion should encourage economic evaluations for the inclusion of new drugs in health insurance plans in both developed and developing countries.

PEDIATRIC PULMONOLOGY (2021)

添加到收藏夹

Article Pediatrics

Cost of illness of RSV infection in a middle-income tropical country

Jefferson Antonio Buendia et al.

Summary: This study aimed to describe the economic burden of RSV in the first two years of life in Colombia, finding that the mean cost per patient with RSV infection was $178.35, with a total cost per year of $64,443,616. The cost per patient with RSV infection was only sensitive to changes in the cost of recurrent wheezing, cost of outpatient visits, and cost of hospitalizations.

TURKISH JOURNAL OF PEDIATRICS (2021)

添加到收藏夹

Article Economics

Costs of Respiratory Syncytial Virus Hospitalizations in Colombia

Jefferson Antonio Buendia et al.

Summary: The study aimed to evaluate the medical costs associated with bronchiolitis hospitalizations caused by RSV infection among infants aged < 2 years in Colombia. It found that RSV infection places a high economic burden on the health system in Colombia, highlighting the need for cost-effectiveness models and RSV prevention strategies.

PHARMACOECONOMICS-OPEN (2021)

添加到收藏夹

Article Pediatrics

The cost-utility of intravenous magnesium sulfate for treating asthma exacerbations in children

Jefferson A. Buendia et al.

PEDIATRIC PULMONOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Treatment outcomes of Pumani bubble-CPAP versus oxygen therapy among preterm babies presenting with respiratory distress at a tertiary hospital in Tanzania-Randomised trial

Annette Baine Mwatha et al.

PLOS ONE (2020)

添加到收藏夹

Article Health Care Sciences & Services

The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis

Jefferson Antonio Buendia et al.

BMC HEALTH SERVICES RESEARCH (2020)

添加到收藏夹

Article Economics

The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment

Sabine Elisabeth Grimm et al.

PHARMACOECONOMICS (2017)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology

Renjithkumar Kalikkot Thekkeveedu et al.

RESPIRATORY MEDICINE (2017)

添加到收藏夹

Article Obstetrics & Gynecology

Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort

Tracy A. Manuck et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)

添加到收藏夹

Article Health Care Sciences & Services

Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample: A Nonparametric Regression Approach

Mark Strong et al.

MEDICAL DECISION MAKING (2014)

添加到收藏夹

Article Pediatrics

Improving Decision Analyses: Parent Preferences (Utility Values) for Pediatric Health Outcomes

Aaron E. Carroll et al.

JOURNAL OF PEDIATRICS (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.